Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Retained Earnings

Retained Earnings at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$17.39B+7.7%
AptarGroup logo
AptarGroupATR
$2.68B+11.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$204.84M-57.1%
AVT
AvantorAVTR
$1.75B-24.8%
Dow logo
DowDOW
$16.46B-12.3%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
-$24.2B-2.3%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$23.75B+32.5%
Enterprise value$23.63B+33.4%
P/E42×+5.3×
P/S7.1×+1.1×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's retained earnings?
West Pharmaceutical Services (WST) reported retained earnings of $4.62B in Q2 2026.
How has West Pharmaceutical Services's retained earnings changed year-over-year?
West Pharmaceutical Services's retained earnings increased by 11.7% year-over-year, from $4.14B to $4.62B.
What is the long-term trend for West Pharmaceutical Services's retained earnings?
Over 5 years (2020 to 2025), West Pharmaceutical Services's retained earnings has grown at a 18.8% compound annual growth rate (CAGR), from $1.85B to $4.37B.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.